XML 37 R24.htm IDEA: XBRL DOCUMENT v3.25.3
Restructuring Expenses
 9 Months Ended
Sep. 30, 2025
Restructuring and Related Activities [Abstract]  
Restructuring Expenses Restructuring Expenses
On April 26, 2024, the Company’s management committed to the wind down of the Company’s Medimat Robotic Dispensing System (“RDS”) product line, subject to local law and statutory works council consultation requirements. During the three and nine months ended September 30, 2024, the Company incurred approximately $0.6 million and $4.1 million, respectively, of employee severance costs and other expenses related to the RDS product line wind down, net of immaterial reversals of previously recognized restructuring expenses. In addition, during the nine months ended September 30, 2024, the Company incurred $5.4 million of inventory write-down charges related to the RDS product line wind down that were recorded to cost of revenues in the Company’s Condensed Consolidated Statements of Operations. During the three and nine months ended September 30, 2025, the Company did not incur any material restructuring expenses.
The following table summarizes the total employee-related restructuring expense recognized in the Company’s Condensed Consolidated Statements of Operations:
Three Months Ended September 30,Nine Months Ended September 30,
20242024
(In thousands)
Cost of product and service revenues$642 $3,338 
Research and development(15)296 
Selling, general, and administrative(7)149 
Total restructuring expense$620 $3,783